Arcturus San Diego Startup Venture Capital 
socalTECH
JUNE 19, 2009
San Diego-based Sorrento Therapeutics , a new biotechnology startup, has raised $2.3M Dr. Schuh was previously CEO and Director of AviaraDx, and also served at Arcturus Bioscience and Sequenom. Schuh was previously CEO and Director of AviaraDx, and also served at Arcturus Bioscience and Sequenom.
Xconomy
MARCH 2, 2018
Biotech startups rolled in cash this week. By our count, investors put more than $800 million into life-sciences startups in four days. The money came from a wide range of backers, not just traditional biotech venture firms. billion, a figure compiled in the Venture Monitor Report.
Xconomy
FEBRUARY 9, 2018
Added up, the highly anticipated data led to a small stock dip and lots. First, Bristol changed the trial’s structure midstream. Second, it still hasn’t proven whether the combination helps patients more than its immunotherapy drug nivolumab (Opdivo) used alone. More results are still to come.
Expert insights. Personalized for you.
100 
Let's personalize your content